WHO Expert Committee on Specifications for Pharmaceutical Preparations - WHO Technical Report Series, No. 885 - Thirty-fifth Report
(1999; 168 pages) [Spanish] View the PDF document
Table of Contents
View the documentWHO Expert Committee on Specifications for Pharmaceutical Preparations
View the document1. Introduction
Open this folder and view contents2. The international pharmacopoeia and related issues
Open this folder and view contents3. International Chemical Reference Substances and Infrared Reference Spectra
Open this folder and view contents4. Quality control - national laboratories
Open this folder and view contents5. Good manufacturing practices
Open this folder and view contents6. Quality systems and inspection
Open this folder and view contents7. Other quality assurance topics
Open this folder and view contents8. Nomenclature and terminology
Open this folder and view contents9. Legal aspects of pharmaceuticals
Open this folder and view contents10. Regulatory issues
Close this folder11. Training activities
View the document11.1 Training programmes for drug regulators and related activities
View the document11.2 Training programmes for the detection of counterfeit pharmaceutical products
View the document12. Pharmaceuticals contaminated with diethylene glycol
View the documentAcknowledgements
View the documentReferences
View the documentAnnex 1. List of available International Chemical Reference Substances1
View the documentAnnex 2. List of available International Infrared Reference Spectra1
Open this folder and view contentsAnnex 3. General guidelines for the establishment, maintenance and distribution of chemical reference substances
Open this folder and view contentsAnnex 4. Good manufacturing practices: authorized person - role, functions and training
Open this folder and view contentsAnnex 5. Good manufacturing practices: supplementary guidelines for the manufacture of pharmaceutical excipients
Open this folder and view contentsAnnex 6. Guidelines for inspection of drug distribution channels
View the documentAnnex 7. Good pharmacy practice in community and hospital pharmacy settings
Open this folder and view contentsAnnex 8. National drug regulatory legislation: guiding principles for small drug regulatory authorities
Open this folder and view contentsAnnex 9. Provisional guidelines for developing training programmes: inspection and examination of counterfeit pharmaceuticals
View the documentWorld Health Organization Technical Report Series
View the documentSelected WHO Publications of Related Interest
View the documentBack Cover
 

11.1 Training programmes for drug regulators and related activities

The Committee was informed of the wide diversity of relevant training activities in which WHO, through its Division of Drug Management and Policies, had been involved. These activities include the following:

• Individual training in drug regulatory agencies in more advanced countries.

 

• Regional training seminar on the technical assessment of dossiers for marketing authorization, organized by the German Foundation for International Development (DSE).

• Seminar on quality assurance for drug regulators, organized by the International Federation of Pharmaceutical Manufacturers Association (IFPMA).

• Individual training for analysts and inspectors, offered by the IFPMA and the World Federation of Proprietary Medicine Manufacturers.

• Regional seminar on GMP, organized by FIP in cooperation with the West African Pharmaceutical Federation.

• Training in the use of the WHO model package designed to support computer-assisted drug registration.

• The 12-month Master of Science course in pharmaceutical services and medicines control, Bradford, England, targeted primarily at pharmacists working in the public sector in developing countries and also at the newly independent States of the former Soviet Union.

 

WHO's Regional Offices and its Action Programme on Essential Drugs are involved in training activities for drug regulators, often through the relevant WHO Collaborating Centres.

The Committee was also informed about a recently created one-year university programme on the development and international registration of medicines at the Faculty of Pharmacy of the University of Paris-Sud, France.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014